Orange juice may boost insulin sensitivity in overweight women
NCT ID NCT01201603
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether drinking orange juice every day can help overweight women become more sensitive to insulin, a hormone that controls blood sugar. Thirty-six women will drink either orange juice or a sugary orange drink for three months. Researchers will measure insulin sensitivity, blood fats, and gene activity in fat tissue to see if the antioxidants in orange juice make a difference.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- orange juice
- What this could lead to
- If it works, this could point toward dietary recommendations for improving insulin sensitivity in overweight individuals.
- What could go wrong
- This is a small, early-stage study with only 36 participants. Results may not apply to the general population, and any benefits could be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Nottingham
Nottingham, Notts, NG7 2UH, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A fiber supplement may help perimenopausal women — a trial puts it to the test
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- A daily pill for obesity? zenagamtide faces its biggest test yet.